Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
4D Molecular Therapeutics | FDMT | 23. dec 2024 | 5.88 | -6.81 |
51Talk Online Education Group ADR | COE | 23. dec 2024 | 17.45 | -1.30 |
5E Advanced Materials | FEAM | 23. dec 2024 | 0.44 | -6.13 |
60 Degrees Pharmaceuticals | SXTP | 23. dec 2024 | 1.16 | -7.94 |
7-10 Yr Trsy Bear 3X Direxion | TYO | 23. dec 2024 | 14.94 | +0.79 |
7-10 Yr Trsy Bull 3X Direxion | TYD | 23. dec 2024 | 23.37 | -2.30 |
7-10 Yr Trsy Ishares | IEF | 23. dec 2024 | 92.20 | -0.44 |
89bio | ETNB | 23. dec 2024 | 7.99 | +0.63 |
8x8 | EGHT | 23. dec 2024 | 2.70 | -0.74 |
908 Devices | MASS | 23. dec 2024 | 1.90 | -7.77 |
9F ADR | JFU | 23. dec 2024 | 1.50 | 0.00 |
A SPAC II Acquisition | ASCB | 23. dec 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | 23. dec 2024 | 25.35 | -1.71 |
a.k.a Brands | AKA | 23. dec 2024 | 21.34 | -0.70 |
A.O Smith | AOS | 23. dec 2024 | 68.56 | -0.23 |
A10 Networks | ATEN | 23. dec 2024 | 18.51 | -0.05 |
A2Z Cust2Mate Solutions | AZ | 23. dec 2024 | 7.15 | -0.69 |
AA Mission Acquisition | AAM | 23. dec 2024 | 10.09 | +0.09 |
AAA - A Rated Corporate Bond Ishares | QLTA | 23. dec 2024 | 46.71 | -0.21 |
Aadi Bioscience | AADI | 23. dec 2024 | 2.86 | -15.63 |
AAON | AAON | 23. dec 2024 | 123.21 | -0.74 |
AAR | AIR | 23. dec 2024 | 59.86 | -1.17 |
Abacus Life | ABL | 23. dec 2024 | 7.80 | +1.04 |
Abbott Laboratories | ABT | 23. dec 2024 | 114.31 | +0.07 |
AbbVie | ABBV | 23. dec 2024 | 178.39 | +1.60 |
AbCellera Biologics | ABCL | 23. dec 2024 | 2.92 | +2.46 |
Abeona Therapeutics | ABEO | 23. dec 2024 | 5.69 | -0.18 |
Abercrombie & Fitch | ANF | 23. dec 2024 | 152.96 | -1.04 |
Aberdeen Asia-Pacificome Fund | FAX | 23. dec 2024 | 15.26 | +0.13 |
Aberdeen Australia Equity Fund | IAF | 23. dec 2024 | 4.27 | +1.91 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.